Trurapi: First insulin aspart biosimilar launched

Trurapi is available in cartridges designed to fit the JuniorSTAR and AllStar Pro devices, and as a pre-filled SoloStar pen. It is licensed for treating diabetes in adults, adolescents and children aged 1 year and above and found to be clinically equivalent to Novorapid in trials

Monthly Index of Medical Specialities